TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
MANE

Veradermics, Incorporated

Healthcare · Biotechnology

115.00$ -1.3% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

Veradermics, Incorporated (MANE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MANE
Line item 2023 2024 2025
0.0 0.0 0.0
15 23 62
2.4 3.5 10
17 27 72
-17 -27 -72
0.0 0.6 0.0
-16 -26 -70
-16 -26 -70
-16 -26 -70

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?